| 英文别名 |
amiloride;3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide;5-(N,N-HEXAMETHYLENE)-AMILORIDE;3-amino-5-azepan-1-yl-6-chloro-pyrazine-2-carboxylic acid carbamimidoylamide;Hexamethyleneamiloride;HMA;HMA-5;amipromizide;AMILORIDE,5-(N,N-HEXAMETHYLENE)-;HMA (5-(N,N-Hexamethylene)amiloride);5-(N,N-Hexamethylene)amiloride Solution, 100ppm;3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylene)pyrazinamide;H+ ANTIPORTER INH;AMILORIDE, 5-(N,N-HEXAMETHYLENE) >93% NA +/H+ ANTIPORTER INH;5-(N,N-Hexamethylene)-amiloride;HY-128067;CHEBI:76400;3-amino-5-(azepan-1-yl)-N-carbamimidoyl-6-chloropyrazine-2-carboxamide;KBio1_001819;CCG-221408;BRD-K40990712-001-02-4;NCGC00095333-01;Spectrum4_000623;NCGC00015108-06;NCGC00015108-04;Spectrum5_001388;5-(N,N-Hexamethylene)amiloride;BSPBio_003443;PDSP2_001064;5-(N,N-hexamethylene)-Amiloride;1428-95-1;3-Amino-6-chloro-5-(1-homopiperidyl)-N-(diaminomethylene)pyrazinecarboxamide;CCG-39661;MS-24542;Spectrum2_001669;NCGC00015108-01;NCGC00095333-02;Spectrum_001596;KBio2_004644;5-HMA;SDCCGSBI-0050092.P003;NCGC00015108-03;Q27073995;NCGC00093601-02;Tox21_500104;NCGC00015108-05;FT-0739004;NSC_1794;Lopac0_000104;J-007715;SMR001230687;1ST10507;Hexamethylene amiloride;CAS_1794;CHEMBL501701;SPECTRUM1504215;SR-01000075696-1;N,N-HEXAMETHYLENEAMILORIDE;KBioSS_002076;KBio2_002076;SPBio_001857;PDSP1_001080;MFCD00069211;KBio3_002663;NCGC00260789-01;BDBM81818;MLS002153208;SCHEMBL7862943;3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide;Pyrazinecarboxamide, 3-amino-N-(aminoiminomethyl)-6-chloro-5-(hexahydro-1H-azepin-1-yl)-;DTXSID10162188;CS-0095166;LP00104;HMS2233N17;Spectrum3_001662;NCGC00093601-01;3-Amino-N-(aminoiminomethyl)-6-chloro-5-(hexahydro-1H-azepin-1-yl)pyrazinecarboxamide;AKOS040758618;DivK1c_006875;SCHEMBL9852488;SR-01000075696;NS00100942;Lopac-A-9561;KBioGR_001206;1345839-29-3;BIDD:GT0357;GTPL1192;KBio2_007212;EU-0100104;Hexamethylene amiloride;HMA;NCGC00015108-02;SpecPlus_000779;HMS3260E10;NCGC00015108-09;A 9561;hma |